Chu Chang An, Galassetti Pietro, Igawa Kayano, Sindelar Dana K, Neal Doss W, Burish Mark, Cherrington Alan D
Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, USA.
Am J Physiol Endocrinol Metab. 2003 Feb;284(2):E291-301. doi: 10.1152/ajpendo.00565.2001.
To determine the effects of an increase in lipolysis on the glycogenolytic effect of epinephrine (EPI), the catecholamine was infused portally into 18-h-fasted conscious dogs maintained on a pancreatic clamp in the presence [portal (Po)-EPI+FFA, n = 6] and absence (Po-EPI+SAL, n = 6) of peripheral Intralipid infusion. Control groups with high glucose (70% increase) and free fatty acid (FFA; 200% increase; HG+FFA, n = 6) and high glucose alone (HG+SAL, n = 6) were also included. Hepatic sinusoidal EPI levels were elevated (Delta 568 +/- 77 and Delta 527 +/- 37 pg/ml, respectively) in Po-EPI+SAL and EPI+FFA but remained basal in HG+FFA and HG+SAL. Arterial plasma FFA increased from 613 +/- 73 to 1,633 +/- 101 and 746 +/- 112 to 1,898 +/- 237 micromol/l in Po-EPI+FFA and HG+FFA but did not change in EPI+SAL or HG+SAL. Net hepatic glycogenolysis increased from 1.5 +/- 0.3 to 3.1 +/- 0.4 mg x kg(-1) x min(-1) (P < 0.05) by 30 min in response to portal EPI but did not rise (1.8 +/- 0.2 to 2.1 +/- 0.3 mg x kg(-1) x min(-1)) in response to Po-EPI+FFA. Net hepatic glycogenolysis decreased from 1.7 +/- 0.2 to 0.9 +/- 0.2 and 1.6 +/- 0.2 to 0.7 +/- 0.2 mg x kg(-1) x min(-1) by 30 min in HG+FFA and HG+SAL. Hepatic gluconeogenic flux to glucose 6-phosphate increased from 0.6 +/- 0.1 to 1.2 +/- 0.1 mg x kg(-1) x min(-1) (P < 0.05; by 3 h) and 0.7 +/- 0.1 to 1.6 +/- 0.1 mg x kg(-1) x min(-1) (P < 0.05; at 90 min) in HG+FFA and Po-EPI+FFA. The gluconeogenic parameters remained unchanged in the Po-EPI+SAL and HG+SAL groups. In conclusion, increased FFA markedly changed the mechanism by which EPI stimulated hepatic glucose production, suggesting that its overall lipolytic effect may be important in determining its effect on the liver.
为了确定脂肪分解增加对肾上腺素(EPI)糖原分解作用的影响,将儿茶酚胺经门静脉注入禁食18小时的清醒犬体内,这些犬在胰腺钳夹状态下分别处于外周输注英脱利匹特(Po-EPI+FFA,n = 6)和未输注(Po-EPI+SAL,n = 6)的情况下。还纳入了高血糖(升高70%)和游离脂肪酸(FFA;升高200%;HG+FFA,n = 6)以及单独高血糖(HG+SAL,n = 6)的对照组。Po-EPI+SAL组和EPI+FFA组肝窦EPI水平升高(分别为Δ568±77和Δ527±37 pg/ml),但HG+FFA组和HG+SAL组保持在基础水平。Po-EPI+FFA组和HG+FFA组动脉血浆FFA从613±73升至1633±101以及从746±112升至1898±237 μmol/l,但EPI+SAL组或HG+SAL组未发生变化。门静脉注射EPI后30分钟,肝脏净糖原分解从1.5±0.3升至3.1±0.4 mg·kg⁻¹·min⁻¹(P<0.05),但Po-EPI+FFA组未升高(从1.8±0.2升至2.1±0.3 mg·kg⁻¹·min⁻¹)。HG+FFA组和HG+SAL组肝脏净糖原分解在30分钟时从1.7±0.2降至0.9±0.2以及从1.6±0.2降至0.7±0.2 mg·kg⁻¹·min⁻¹。HG+FFA组和Po-EPI+FFA组中,肝脏向6-磷酸葡萄糖的糖异生通量在3小时时从0.6±0.1升至1.2±0.1 mg·kg⁻¹·min⁻¹(P<0.05)以及在90分钟时从0.7±0.1升至1.6±0.